000566.SHE Hainan Haiyao Co Ltd
- Market cap
- CNY 5.07B
- P/E
- -
- P/B
- 1,470.22x
- ROE
- -
- Dividend yield
- 1.95%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000566.SHE undervalued?
Graham numberThe Graham number of Hainan Haiyao Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hainan Haiyao Co Ltd fundamental analysis
No fundamental analysis for Hainan Haiyao Co Ltd yet.
Hainan Haiyao Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hainan Haiyao Co Ltd
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers big health, digestive, anti-infective, respiratory, anti-tumor, vitamins, and chronic disease category products. It also provides active pharmaceutical ingredients and intermediates; traditional Chinese medicine decoction pieces; medical devices, including disposable medical mask, implant, and source processor; and medical services. In a…
Full company profileHainan Haiyao Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hainan Haiyao Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.51B | 1.82B | 2.47B | 2.45B | 2.20B | 2.06B | 1.78B | 1.48B | 991M | 831M | 642M |
| Gross Profit | 789M | 876M | 1.31B | 1.24B | 961M | 826M | 768M | 571M | 322M | 206M | 98.1M |
| Operating Income | 159M | 110M | 158M | -123M | -709M | -1.55B | -61.5M | -121M | -1.55B | -196M | -309M |
| EBITDA | 294M | 300M | 352M | -262M | -337M | -521M | 25.0M | 158M | -442M | -23.1M | -305M |
| Net Income | 165M | 86.6M | 120M | -159M | -580M | -1.56B | 10.5M | -106M | -1.53B | -430M | -460M |
| EPS | 0.14 | 0.06 | 0.09 | -0.12 | -0.45 | -1.20 | 0.01 | -0.08 | -1.18 | -0.33 | -0.35 |
| Balance Sheet | |||||||||||
| Total Assets | 9.61B | 10.5B | 10.3B | 10.8B | 10.3B | 8.36B | 7.37B | 7.37B | 6.11B | 5.71B | 5.40B |
| Total Liabilities | 3.98B | 5.47B | 5.51B | 6.15B | 6.31B | 5.98B | 5.03B | 5.17B | 5.52B | 5.59B | 5.65B |
| Shareholders' Equity | 5.43B | 4.85B | 4.61B | 4.46B | 3.71B | 2.15B | 2.16B | 2.06B | 525M | 81.8M | -265M |
| Cash & Short-term Investments | 3.19B | 3.97B | 3.63B | 3.63B | 2.95B | 1.60B | 975M | 933M | 522M | 346M | 223M |
| Total Debt | 2.10B | 3.48B | 4.50B | 3.42B | 4.40B | 3.28B | 3.40B | 2.69B | 2.53B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -17.7M | 526M | -509M | -196M | -117M | 108M | 142M | 104M | -17.6M | 79.8M | - |
| Capital Expenditure | 175M | 769M | 565M | 468M | 769M | 415M | 264M | 211M | 176M | 143M | 171M |
| Free Cash Flow | -193M | -243M | -1.07B | -664M | -886M | -307M | -122M | -107M | -193M | -63.4M | -214M |
| Ratios | |||||||||||
| ROE | 3.0% | 1.8% | 2.6% | -3.6% | -15.7% | -72.4% | 0.5% | -5.2% | -290.4% | -525.8% | - |
| ROA | 1.7% | 0.8% | 1.2% | -1.5% | -5.6% | -18.6% | 0.1% | -1.4% | -24.9% | -7.5% | -8.5% |
| Net Profit Margin | 10.9% | 4.7% | 4.8% | -6.5% | -26.4% | -75.5% | 0.6% | -7.2% | -154.0% | -51.7% | -71.7% |
| Debt to Equity | 0.39x | 0.72x | 0.98x | 0.77x | 1.19x | 1.53x | 1.57x | 1.30x | 4.81x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hainan Haiyao Co Ltd dividends
- Dividend yield
- 1.95%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Aug 15, 2018
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 99.1M | 0.08 | - |
| 2024 | CNY 114M | 0.09 | - |
| 2023 | CNY 139M | 0.11 | - |
| 2022 | CNY 167M | 0.13 | 1,587.3% |
| 2021 | CNY 172M | 0.13 | - |
| 2020 | CNY 205M | 0.16 | - |
| 2019 | CNY 297M | 0.22 | - |
| 2018 | CNY 421M | 0.32 | 352.4% |
| 2017 | CNY 404M | 0.28 | 466.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on May 31, 2016.
Who owns Hainan Haiyao Co Ltd
- Insiders 35.80%
- Institutions 4.90%
- Public & others 59.30%
- Shares outstanding 1.30B
- Free float 941M
Hainan Haiyao Co Ltd company profile
- Company name
- Hainan Haiyao Co Ltd
- Ticker
- 000566.SHE
- ISIN
- CNE0000004W8
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Jan 10, 1994
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 1,738
- Fiscal year end
- December
- Address
- No. 192, Nanhai Avenue, Haikou, China, 570311
- Phone
- 86 89 8363 30888
- Website
- haiyao.com.cn
About Hainan Haiyao Co Ltd
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers big health, digestive, anti-infective, respiratory, anti-tumor, vitamins, and chronic disease category products. It also provides active pharmaceutical ingredients and intermediates; traditional Chinese medicine decoction pieces; medical devices, including disposable medical mask, implant, and source processor; and medical services. In addition, the company offers chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, and cell immunotherapy. Hainan Haiyao Co., Ltd. was founded in 1965 and is headquartered in Haikou, China.
Hainan Haiyao Co Ltd management
5- Mr. Guihao PanGM & Director · born 1981
- Mr. Haifeng YinChief Engineer · born 1972
- Mr. Lei ShiDeputy GM & Secretary of the Board of Directors · born 1986
- Mr. Yong TianDeputy General Manager · born 1981
- Mr. Wei WangDeputy General Manager · born 1980